BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 25875125)

  • 1. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials.
    Catalá-López F; Hutton B; Núñez-Beltrán A; Mayhew AD; Page MJ; Ridao M; Tobías A; Catalá MA; Tabarés-Seisdedos R; Moher D
    Syst Rev; 2015 Feb; 4():19. PubMed ID: 25875125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials.
    Catalá-López F; Hutton B; Núñez-Beltrán A; Page MJ; Ridao M; Macías Saint-Gerons D; Catalá MA; Tabarés-Seisdedos R; Moher D
    PLoS One; 2017; 12(7):e0180355. PubMed ID: 28700715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity disorder and their first-degree relatives: a protocol for a systematic review and meta-analysis of observational studies.
    Catalá-López F; Hutton B; Page MJ; Ridao M; Driver JA; Alonso-Arroyo A; Forés-Martos J; Macías Saint-Gerons D; Vieta E; Valencia A; Tabarés-Seisdedos R
    Syst Rev; 2017 Sep; 6(1):189. PubMed ID: 28915839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
    Cortese S; Adamo N; Mohr-Jensen C; Hayes AJ; Bhatti S; Carucci S; Del Giovane C; Atkinson LZ; Banaschewski T; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A; Coghill D;
    BMJ Open; 2017 Jan; 7(1):e013967. PubMed ID: 28073796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.
    Storebø OJ; Skoog M; Damm D; Thomsen PH; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008223. PubMed ID: 22161422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Otasowie J; Castells X; Ehimare UP; Smith CH
    Cochrane Database Syst Rev; 2014 Sep; (9):CD006997. PubMed ID: 25238582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neurofeedback versus methylphenidate for the treatment of attention-deficit/hyperactivity disorder protocol for a systematic review and meta-analysis of head-to-head trials.
    Yan L; Zhang J; Yuan Y; Cortese S
    Medicine (Baltimore); 2018 Sep; 97(39):e12623. PubMed ID: 30278582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) delivered in school settings: systematic reviews of quantitative and qualitative research.
    Richardson M; Moore DA; Gwernan-Jones R; Thompson-Coon J; Ukoumunne O; Rogers M; Whear R; Newlove-Delgado TV; Logan S; Morris C; Taylor E; Cooper P; Stein K; Garside R; Ford TJ
    Health Technol Assess; 2015 Jun; 19(45):1-470. PubMed ID: 26129788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic review with updated meta-analysis of observational studies.
    Catalá-López F; Ridao M; Núñez-Beltrán A; Gènova-Maleras R; Alonso-Arroyo A; Aleixandre-Benavent R; Catalá MA; Tabarés-Seisdedos R
    Syst Rev; 2019 Feb; 8(1):49. PubMed ID: 30744675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of monotherapies and combination therapies for patients with hypertension: protocol for a systematic review with network meta-analyses.
    Hutton B; Tetzlaff J; Yazdi F; Thielman J; Kanji S; Fergusson D; Bjerre L; Mills E; Thorlund K; Tricco A; Straus S; Moher D; Leenen FH
    Syst Rev; 2013 Jun; 2():44. PubMed ID: 23809864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-pharmacological sleep interventions for pediatric cancer patients and survivors: a systematic review protocol.
    Stavinoha PL; Olsthoorn IM; Swartz MC; Nowakowski S; Wells SJ; Hicklen RS; Sheikh I; Jang HJ
    Syst Rev; 2021 Jun; 10(1):166. PubMed ID: 34088350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network meta-analysis of randomised trials of pharmacological, psychotherapeutic, exercise and collaborative care interventions for depressive symptoms in patients with coronary artery disease: hybrid systematic review of systematic reviews protocol.
    Doyle F; Freedland K; Carney R; de Jonge P; Dickens C; Pedersen S; Sorensen J; Dempster M
    Syst Rev; 2019 Mar; 8(1):71. PubMed ID: 30878039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of acupuncture on childhood attention deficit hyperactivity disorder: A protocol for systematic review and meta-analysis.
    Lin Y; Jin H; Huang B; Zhao N; Li Z; Mao J; Chen C; Xu J; Zhang J; Shuai B
    Medicine (Baltimore); 2021 Feb; 100(5):e23953. PubMed ID: 33592848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.
    Wu EQ; Hodgkins P; Ben-Hamadi R; Setyawan J; Xie J; Sikirica V; Du EX; Yan SY; Erder MH
    CNS Drugs; 2012 Jul; 26(7):581-600. PubMed ID: 22712698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies.
    Catalá-López F; Hutton B; Driver JA; Page MJ; Ridao M; Valderas JM; Alonso-Arroyo A; Forés-Martos J; Martínez S; Gènova-Maleras R; Macías-Saint-Gerons D; Crespo-Facorro B; Vieta E; Valencia A; Tabarés-Seisdedos R
    Syst Rev; 2017 Apr; 6(1):69. PubMed ID: 28376926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review.
    Melton H; Meader N; Dale H; Wright K; Jones-Diette J; Temple M; Shah I; Lovell K; McMillan D; Churchill R; Barbui C; Gilbody S; Coventry P
    Health Technol Assess; 2020 Sep; 24(43):1-312. PubMed ID: 32924926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative cardiovascular side effects of medications for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
    Lannes A; Farhat LC; Del Giovane C; Cipriani A; Revet A; Cortese S
    BMJ Open; 2022 Sep; 12(9):e062748. PubMed ID: 36167386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.